Crypto Political Action Committee Increases Primary Spending, <i>Clarity Act</i> Sees Key Advancement Window
BlockBeats News, June 22nd. According to Crypto in America, as the US Congress entered a two-week recess before this Thursday, the cryptocurrency industry is actively advancing the
Meanwhile, the Cryptocurrency Political Action Committee continues to increase its support for pro-crypto candidates. Protect Progress, a subsidiary of Fairshake, has invested approximately $5.5 million in Maryland's 5th District Democratic primary candidate Adrian Boafo and about $1.5 million in the re-election campaign of New York's 15th District Congressman Ritchie Torres. The Blockchain Leadership Fund, supported by Anchorage Digital and Chainlink, is also involved in supporting Boafo.
In addition, Fairshake allocated around $12 million last week to help Alabama Republican Senate primary candidate Barry Moore secure victory.
The industry organization Digital Chamber will hold a lobbying event on Capitol Hill this week to promote the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Swiss Franc weakens as US Dollar (USD) gains on escalating geopolitical conflicts
Swiss Franc: Range-bound within 0.8245–0.8365 band against US Dollar – UOB
BUZZ-Genmab shares hit a three-year high as blood cancer drug combination study results are released
October 6 - Genmab (GMAB.CO) shares rose about 8%, reaching a three-year high and leading the STOXX 600 index (.STOXX). Genmab and AbbVie ABBV.N announced on Monday (link) that their combination therapy for blood cancer reduced the risk of disease progression and death in a late-stage clinical trial. The two companies stated that, compared to R-CHOP regimen alone, the combination therapy reduced the risk of disease progression or death in newly diagnosed patients by 51%. Analysts at Jefferies described this result as "impressive". The brokerage added that the data "easily met the bar for success" and exceeded investor expectations of approximately 40%. TD Cowen stated that the data establishes the combination therapy as a potential new standard of care, with peak market potential expected to exceed $3 billion. (For convenience of non-English speakers, Reuters has automated this report into several other languages. Automated translations may contain errors or lack necessary context, and Reuters makes no guarantees as to their accuracy. The automated translation is provided for reader convenience, and Reuters bears no responsibility for any damages or losses resulting from use of the automated translation.)
Crypto prices
More
